Asthma Clinical Trials U.S.

New Asthma Trials Shows Promise

press reports published today reflect that a new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said on Tuesday.

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus

Condition:   AsthmaInterventions:   Drug: Seretide Diskus and charcoal;   Drug: Seretide Diskus;   Drug: SF Easyhaler and charcoal;   Drug: SF EasyhalerSponsors:   Orion Corporation, Orion Pharma;   Orion Corporation, Orion PharmaRecruiting – verified May 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Nutrition and Asthma

The Role of Nutrition and Nutritional Supplements in Asthma Nutrition and Nutritional Supplements in Asthma Interview with Nicholas Kenyon, M.D. Associate Professor of Medicine Division of Pulmonary and Critical Care Medicine University of California, Davis. We learn about: * Increased…

Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

Condition:   AsthmaInterventions:   Drug: CHF1535 pMDI + AC Plus;   Drug: BDP + AC Plus;   Drug: Formoterol + AC PlusSponsors:   Chiesi Farmaceutici S.p.A.;   Chiesi Farmaceutici S.p.A.Completed – verified May 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

CLINICAL PHARMACOLOGY STUDY OF A FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 50µg PLUS FORMOTEROL FUMARATE 6 µg VERSUS THE FREE COMBINATION OF BECLOMETHASONE HFA pMDI AND FORMOTEROL HFA pMDI AVAILABLE ON THE MARKET USING THE AEROCHAMBER PLUS™ SPACER DEVICE IN ASTHMATIC CHILDREN

Condition:   AsthmaInterventions:   Drug: CHF1535 pMDI + AC Plus;   Drug: BDP and Formoterol + AC PlusSponsors:   Chiesi Farmaceutici S.p.A.;   Chiesi Farmaceutici S.p.A.Completed – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Study of Safety of Foradil in Patients With Persistent Asthma

Condition:   Persistent AsthmaInterventions:   Drug: Formoterol;   Drug: Fluticasone propionate 100 mcg;   Drug: Fluticasone propionate 250 mcg;   Drug: Fluticasone propionate 500 mcg;   Drug: PlaceboSponsors:   Novartis;   Novartis PharmaceuticalsNot yet recruiting – verified April 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days